73
Views
0
CrossRef citations to date
0
Altmetric
Letter to the editor

Reply: empagliflozin effects on cardiac remodeling: re-shaping the future of heart failure prevention

, &
Pages 101-102 | Received 17 Aug 2020, Accepted 30 Sep 2020, Published online: 27 Oct 2020
 

Declaration of interest

This research was supported by an independent grant from Boehringer Ingelheim Pharmaceuticals, which provided both drug and financial support for the study.

The authors report that they have no relationships relevant to the contents of this paper to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.